13F HOLDINGS REPORT
venBio Partners LLC
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0000905148-23-000261
Total Value
$322.5M
Positions
7
Other Managers
0
Confidential Omitted
No
Holdings (7)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | VENTYX BIOSCIENCES INC | 92332V107 | 3,461,536 | $113.5M | 35.19% |
| 2 | ALX ONCOLOGY HLDGS INC | ALXO | 9,699,925 | $109.3M | 33.89% |
| 3 | HARMONY BIOSCIENCES HLDGS IN | HRMY | 1,035,396 | $57.1M | 17.69% |
| 4 | PHARVARIS N V | PHVS | 2,296,710 | $25.8M | 8.01% |
| 5 | IMPEL PHARMACEUTICALS INC | 45258K109 | 2,759,791 | $10.3M | 3.21% |
| 6 | CINCOR PHARMA INC | 17240Y109 | 383,390 | $4.7M | 1.46% |
| 7 | ELEVATION ONCOLOGY INC | 28623U101 | 1,866,339 | $1.8M | 0.55% |